Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IVSusanne Saußele, Anthony D. Ho, Christiane Falge et al.|Blood|2009Cited by 220
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Peter Dreger, Stephan Stilgenbauer et al.|Blood|2004Cited by 170
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Jochen Greiner, Anita Schmitt et al.|Theranostics|2017Cited by 11
Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative DonorMichael Schmitt, Jochen Greiner, Anita Schmitt et al.|Blood|2016Cited by 1